Taper My Antidepressant? No, Not Like That: The Top Withdrawal-Risk Misconceptions That Get People in Trouble
There’s a particular kind of confidence that comes from hearing someone else say, “You don’t really need to taper—just stop.” […]
The 20 Drug Brands AI Talks About Most — And Where Its Answers Diverge From the Record
The short answer: Twenty brand and generic names dominate AI-monitoring query volume tracked across consumer and clinical assistants: Lipitor, Advil,
The OTC vs Prescription Double-Dipping Trap: When One “Same Thing” Turns Into Two
Top OTC vs prescription overlap mistakes (people accidentally doubling up) There are two kinds of medication problems: the ones you
The Dependence Problem: Medications That Can Quietly Turn Into Something Else
There are two kinds of “dependency” in medicine. One is the obvious sort—people miss a dose and feel terrible. The
The Most Dangerous Revenue Stream Is the One You Don’t Control
No pharmaceutical brand team sets a quarterly target for off-label prescriptions. Nobody puts “unauthorized use growth” on a slide for
Before You Pour Another Glass: the “Can I Take This With Alcohol?” Questions People Actually Ask
Alcohol is the universal solvent. It dissolves inhibitions, plans, and—sometimes—drug safety. If you’re taking prescription medicines (especially the ones that
Nobody at Your Company Proofread What ChatGPT Says About Your Drug
About a third of US adults now ask an AI chatbot a health question in a given year, roughly the
The AI Drug Monitoring Platform Buyer’s Guide Nobody Selling One Will Give You
Somewhere right now, a patient is asking ChatGPT whether it is safe to combine two of their prescriptions. A physician
Brand vs. Brand: The Top Drug-Switching Confusion Questions People Keep Asking
Drug switching is supposed to be boring: same active ingredient, same job, fewer surprises. But in the real world, “brand
Oracle Argus vs Veeva Vault Safety vs ArisGlobal LifeSphere: Which PV Platform Actually Fits Your Team
Three vendors control most of the case-processing market that keeps adverse event reports moving from intake to FDA submission. Oracle
The Time-to-Relief Mirage: When “How Long Does This Drug Take to Work?” Meets Reality
There’s a particular kind of hope that shows up in pharmacies and patient portals: the simple question, “How long does
Build vs. Buy: What DIY AI Monitoring Actually Costs Pharma Brand Teams
A brand manager at a mid-size specialty pharma company opens ChatGPT, types her drug’s name, and asks about dosing in
